<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01045070</url>
  </required_header>
  <id_info>
    <org_study_id>F/34/08</org_study_id>
    <nct_id>NCT01045070</nct_id>
  </id_info>
  <brief_title>Periodontitis and Coronary Heart Disease</brief_title>
  <official_title>Periodontitis and Its Microbiological Agents as Prognostic Factors in Patients With Coronary Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Martin-Luther-Universität Halle-Wittenberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The German Heart Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Martin-Luther-Universität Halle-Wittenberg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      &quot;Atherosclerosis is an inflammatory disease&quot;. The hypothesis of an infectious burden as&#xD;
      trigger or initiator of the inflammatory process in atherosclerosis has been extensively&#xD;
      discussed in the past years. One part of this discussion is focused on the infectious agents&#xD;
      responsible for periodontitis. Several studies have found an association of periodontitis&#xD;
      and/or bacteria related to this disease and atherosclerosis. However, a study focussing on&#xD;
      the prognostic relevance of these factors is missing.&#xD;
&#xD;
      The hypothesis of this study is that periodontitis is a prognostic relevant risk factor for&#xD;
      patients with angiographically proven coronary heart disease. Furthermore, the infectious&#xD;
      pathogen burden by PCR-detection of periodontal pathogens will be evaluated as a prognostic&#xD;
      factor.&#xD;
&#xD;
      960 consecutive patients with angiographically proven coronary heart disease will be included&#xD;
      in this study. After inclusion of patients an extensive periodontal examination including&#xD;
      PCR-sampling for 11 bacteria (Porphyromonas gingivitis, Actinobacillus actinomycetemcomitans,&#xD;
      and others) will be performed. After 12 months patient will be follow up for any major&#xD;
      adverse events (cardiovascular death, myocardial infarction, stroke).&#xD;
&#xD;
      If this study will find a relation of periodontitis or its microbiological agents to&#xD;
      cardiovascular outcome of patients with coronary heart disease, further studies are necessary&#xD;
      to investigate potential therapeutic consequences for patients with CHD and periodontitis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Combined endpoint: myocardial infarction, cardiovascular death, stroke</measure>
    <time_frame>12 months follow-up</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">960</enrollment>
  <condition>Periodontitis</condition>
  <condition>Coronary Heart Disease</condition>
  <arm_group>
    <arm_group_label>coronary heart disease</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood-samples and samples from gingival pockets&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with coronary heart disease, admitted to the Martin Luther-University&#xD;
        Halle-Wittenberg&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;18 years&#xD;
&#xD;
          -  Coronary heart disease as defined by previous or current detection of 50% stenosis of&#xD;
             a main coronary artery by coronary angiography or previous or current percutaneous&#xD;
             coronary intervention (PCI) or previous or current coronary artery bypass surgery&#xD;
             (CABG)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to give written informed consent&#xD;
&#xD;
          -  Periodontal treatment and/or antibiotic therapy during the last 6 months&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Current alcohol or drug abuse, or psychological reasons that make study participation&#xD;
             impractical&#xD;
&#xD;
          -  Drugs which are potential causal for gingival hyperplasia (Hydantoin, Nifedipine,&#xD;
             Cyclosporin A, and other)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Axel Schlitt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Medicine III, Martin Luther-University Halle-Wittenberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Martin Luther-University Halle-Wittenberg</name>
      <address>
        <city>Halle (Saale)</city>
        <zip>06097</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <study_first_submitted>January 7, 2010</study_first_submitted>
  <study_first_submitted_qc>January 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2010</study_first_posted>
  <last_update_submitted>May 1, 2012</last_update_submitted>
  <last_update_submitted_qc>May 1, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 2, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Martin-Luther-Universität Halle-Wittenberg</investigator_affiliation>
    <investigator_full_name>Axel Schlitt</investigator_full_name>
    <investigator_title>PD Dr. med. habil.</investigator_title>
  </responsible_party>
  <keyword>periodontitis and coronary heart disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

